Membership

All ISCT Members are required to sign the pledge annually.

I hereby confirm that I have read the following documents; and I have read and agree with the below statement:

• The ISCT reference paper entitled, "On Unproven Cellular Therapies 2015: Talking About Unproven Cell-Based Interventions" (published in the Society's official journal Cytotherapy. Cytotherapy, 2016; 18: 113-148)

• ISCT Statement of Concern Regarding Speculative Commercial Cell Banking Services

I pledge that I will conduct cell, cell product-based, and gene-based therapy practice and promotion in accordance with ISCT’s position on Unproven Cell-Based Interventions and Patient Safety as outlined in above documents. I further pledge that I will not engage in any practice or promotion of cell, cell product-based, or gene-based therapy that is unproven or inconsistent with such positions, noncompliant with applicable ethical or regulatory standards, or that is otherwise unethical. I understand and acknowledge that breach of this pledge is grounds for removal of my membership. ISCT reserves the right to decline an applicant’s request for membership if the Society concludes after review that an applicant’s promotional claims, clinical activities, commercial practices, or other activities, are inconsistent with the Society’s position on unproven cell, cell product-based, or gene-based interventions.

Working with regulatory and scientific experts from around the world, ISCT addresses challenges in evolving global regulatory environments, sets global scientific standards, and ensures the highest ethical principles are upheld in a rapidly changing field.

Showcase your innovations in the Official Journal of ISCT, moving science forward by forecasting key topics and building consensus for cell and gene therapy in a global, translational community. With a 5 year impact factor of 5.0, Cytotherapy adheres to the highest scientific standards and curates the advancements that shape our field.

ISCT members access significantly reduced rates for Annual and Regional Meetings, and other ISCT events and programs throughout the year.

Through a global mentoring program, ongoing training and education resources, and networking opportunities via ISCT Committees and events, ISCT is committed to providing emerging leaders in cell and gene therapy with the resources they need to succeed in the field.

ISCT Awards honor scientific excellence and contributions to the field of cell and gene therapy. ISCT offers a wide variety of awards to members, including the Career Achievement Award, Le Prix Luc Sensebé in Innovation and Leadership, the Darwin J. Prockop Mentoring Award, as well as Annual Meeting Awards and Regional Awards.

Connect and collaborate with a global community of over 3,000 cell and gene therapy professionals, including the most influential thought leaders in the CGT field today.

Through relationships with more than 40 partner organizations, ISCT develops sector-wide consensus on issues at the forefront of the cell and gene therapy field, including unproven cellular therapies and commercial cell banking services, Google’s advertising policies, and regulatory hurdles impacting the advancement of therapies for patients.